The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
CHMP recommendation is based on Phase III data, which demonstrated that darolutamide plus androgen deprivation therapy (ADT) in combination with docetaxel significantly reduced the risk of death by 32.5%
Medical Tourism will boost India’s economy
Multilateral collaborations will serve to strengthen knowledge sharing to formulate framework for accessible, affordable, and quality healthcare
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
The company is preparing a detailed response to the observations, which will be submitted to the USFDA within the stipulated timelines.
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
International Business is expected to post double-digit revenue growth during the quarter in constant currency.
Subscribe To Our Newsletter & Stay Updated
